Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Alector	Denali Therapeutics	Fate Therapeutics	Bill.com	Halozyme Therapeutics
Symbol	NASDAQ:ALEC	NASDAQ:DNLI	NASDAQ:FATE	NASDAQ:RVMD	NASDAQ:HALO
Price Information
Current Price	$32.90	$28.41	$31.97	$33.58	$24.27
52 Week Range	Buy	Buy	Buy	Buy	Buy
Beat the Market™ Rank
Overall Score	1.0	1.2	1.5	1.8	2.2
Analysis Score	1.5	2.4	3.4	4.4	3.4
Community Score	2.5	2.5	3.0	3.2	2.6
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.0	1.0	1.0	1.0	3.0
Earnings & Valuation Score	0.0	0.0	0.0	0.6	1.9
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$29.67	$29.80	$35.88	$45.67	$28.63
% Upside from Price Target	-9.83% downside	4.89% upside	12.24% upside	35.99% upside	17.94% upside
Trade Information
Market Cap	$2.62 billion	$2.94 billion	$2.46 billion	$1.81 billion	$3.30 billion
Beta	1.01	1.88	1.77	N/A	1.74
Average Volume	580,124	615,988	1,081,184	315,675	1,710,010
Sales & Book Value
Annual Revenue	$21.22 million	$26.68 million	$10.68 million	N/A	$195.99 million
Price / Sales	122.53	112.48	232.57	N/A	16.82
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.83 per share	$4.11 per share	$3.24 per share	N/A	$0.63 per share
Price / Book	11.63	6.91	9.87	N/A	38.52
Profitability
Net Income	$-105,390,000.00	$-197,610,000.00	$-98,150,000.00	N/A	$-72,240,000.00
EPS	($1.71)	($2.07)	($1.44)	N/A	($0.50)
Trailing P/E Ratio	N/A	N/A	N/A	0.00	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	15.56
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-556.70%	-825.96%	-1,059.44%	N/A	-48.75%
Return on Equity (ROE)	-48.29%	-46.48%	-52.08%	N/A	-48.92%
Return on Assets (ROA)	-25.78%	-34.60%	-38.45%	N/A	-17.36%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.10%	0.12%	0.34%	N/A	6.66%
Current Ratio	7.75%	12.70%	8.36%	N/A	11.14%
Quick Ratio	7.75%	12.70%	8.36%	N/A	10.15%
Ownership Information
Institutional Ownership Percentage	59.48%	75.03%	97.33%	79.33%	95.37%
Insider Ownership Percentage	13.90%	21.20%	21.41%	N/A	2.60%
Miscellaneous
Employees	91	179	104	N/A	281
Shares Outstanding	79.03 million	105.63 million	77.69 million	59.01 million	135.82 million
Next Earnings Date	8/10/2020 (Estimated)	8/4/2020 (Estimated)	8/4/2020 (Estimated)	8/13/2020 (Estimated)	8/4/2020 (Estimated)
Optionable	Not Optionable	Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources